Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

PLCL/PCL Dressings with Platelet Lysate and Growth Factors Embedded in Fibrin for Chronic Wound Regeneration

J. Táborská, A. Blanquer, E. Brynda, E. Filová, L. Stiborová, V. Jenčová, K. Havlíčková, Z. Riedelová, T. Riedel

. 2023 ; 18 (-) : 595-610. [pub] 20230203

Language English Country New Zealand

Document type Journal Article

INTRODUCTION: The formation of diabetic ulcers (DU) is a common complication for diabetic patients resulting in serious chronic wounds. There is therefore, an urgent need for complex treatment of this problem. This study examines a bioactive wound dressing of a biodegradable electrospun nanofibrous blend of poly(L-lactide-co-ε-caprolactone) and poly(ε-caprolactone) (PLCL/PCL) covered by a thin fibrin layer for sustained delivery of bioactive molecules. METHODS: Electrospun PLCL/PCL nanofibers were coated with fibrin-based coating prepared by a controlled technique and enriched with human platelet lysate (hPL), fibroblast growth factor 2 (FGF), and vascular endothelial growth factor (VEGF). The coating was characterized by scanning electron microscopy and fluorescent microscopy. Protein content and its release rate and the effect on human saphenous vein endothelial cells (HSVEC) were evaluated. RESULTS: The highest protein amount is achieved by the coating of PLCL/PCL with a fibrin mesh containing 20% v/v hPL (NF20). The fibrin coating serves as an excellent scaffold to accumulate bioactive molecules from hPL such as PDGF-BB, fibronectin (Fn), and α-2 antiplasmin. The NF20 coating shows both fast and a sustained release of the attached bioactive molecules (Fn, VEGF, FGF). The dressing significantly increases the viability of human saphenous vein endothelial cells (HSVECs) cultivated on a collagen-based wound model. The exogenous addition of FGF and VEGF during the coating procedure further increases the HSVECs viability. In addition, the presence of α-2 antiplasmin significantly stabilizes the fibrin mesh and prevents its cleavage by plasmin. DISCUSSION: The NF20 coating supplemented with FGF and VEGF provides a promising wound dressing for the complex treatment of DU. The incorporation of various bioactive molecules from hPL and growth factors has great potential to support the healing processes by providing appropriate stimuli in the chronic wound.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004252
003      
CZ-PrNML
005      
20230425141234.0
007      
ta
008      
230418s2023 nz f 000 0|eng||
009      
AR
024    7_
$a 10.2147/IJN.S393890 $2 doi
035    __
$a (PubMed)36760757
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a nz
100    1_
$a Táborská, Johanka $u Department of Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000222357647
245    10
$a PLCL/PCL Dressings with Platelet Lysate and Growth Factors Embedded in Fibrin for Chronic Wound Regeneration / $c J. Táborská, A. Blanquer, E. Brynda, E. Filová, L. Stiborová, V. Jenčová, K. Havlíčková, Z. Riedelová, T. Riedel
520    9_
$a INTRODUCTION: The formation of diabetic ulcers (DU) is a common complication for diabetic patients resulting in serious chronic wounds. There is therefore, an urgent need for complex treatment of this problem. This study examines a bioactive wound dressing of a biodegradable electrospun nanofibrous blend of poly(L-lactide-co-ε-caprolactone) and poly(ε-caprolactone) (PLCL/PCL) covered by a thin fibrin layer for sustained delivery of bioactive molecules. METHODS: Electrospun PLCL/PCL nanofibers were coated with fibrin-based coating prepared by a controlled technique and enriched with human platelet lysate (hPL), fibroblast growth factor 2 (FGF), and vascular endothelial growth factor (VEGF). The coating was characterized by scanning electron microscopy and fluorescent microscopy. Protein content and its release rate and the effect on human saphenous vein endothelial cells (HSVEC) were evaluated. RESULTS: The highest protein amount is achieved by the coating of PLCL/PCL with a fibrin mesh containing 20% v/v hPL (NF20). The fibrin coating serves as an excellent scaffold to accumulate bioactive molecules from hPL such as PDGF-BB, fibronectin (Fn), and α-2 antiplasmin. The NF20 coating shows both fast and a sustained release of the attached bioactive molecules (Fn, VEGF, FGF). The dressing significantly increases the viability of human saphenous vein endothelial cells (HSVECs) cultivated on a collagen-based wound model. The exogenous addition of FGF and VEGF during the coating procedure further increases the HSVECs viability. In addition, the presence of α-2 antiplasmin significantly stabilizes the fibrin mesh and prevents its cleavage by plasmin. DISCUSSION: The NF20 coating supplemented with FGF and VEGF provides a promising wound dressing for the complex treatment of DU. The incorporation of various bioactive molecules from hPL and growth factors has great potential to support the healing processes by providing appropriate stimuli in the chronic wound.
650    _2
$a lidé $7 D006801
650    12
$a vaskulární endoteliální růstový faktor A $7 D042461
650    _2
$a alfa-2-antiplasmin $7 D000979
650    _2
$a polyestery $x farmakologie $7 D011091
650    _2
$a endoteliální buňky $7 D042783
650    _2
$a hojení ran $7 D014945
650    _2
$a obvazy $7 D001458
650    12
$a nanovlákna $7 D057139
655    _2
$a časopisecké články $7 D016428
700    1_
$a Blanquer, Andreu $u Department of Biomaterials and Tissue Engineering, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic $u Departament de Biologia Cellular, Fisiologia i Immunologia, Universitat Autonoma de Barcelona, Bellaterra, Spain $1 https://orcid.org/0000000235511885
700    1_
$a Brynda, Eduard $u Department of Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Filová, Elena $u Department of Biomaterials and Tissue Engineering, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/000000016215197X $7 xx0074200
700    1_
$a Stiborová, Lenka $u Department of Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Jenčová, Věra $u Department of Chemistry, Technical University of Liberec, Liberec, Czech Republic $1 https://orcid.org/0000000173919526 $7 xx0069522
700    1_
$a Havlíčková, Kristýna $u Department of Chemistry, Technical University of Liberec, Liberec, Czech Republic
700    1_
$a Riedelová, Zuzana $u Department of Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Riedel, Tomáš $u Department of Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000229716956 $7 xx0232941
773    0_
$w MED00176143 $t International journal of nanomedicine $x 1178-2013 $g Roč. 18, č. - (2023), s. 595-610
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36760757 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425141231 $b ABA008
999    __
$a ok $b bmc $g 1924741 $s 1190461
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 18 $c - $d 595-610 $e 20230203 $i 1178-2013 $m International journal of nanomedicine $n Int J Nanomedicine $x MED00176143
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...